Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network.
about
Neuron-derived neurotrophic factor functions as a novel modulator that enhances endothelial cell function and revascularization processesLeptin enhances the potency of circulating angiogenic cells via src kinase and integrin (alpha)vbeta5: implications for angiogenesis in human obesityArteriolar remodeling following ischemic injury extends from capillary to large arteriole in the microcirculation.VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.Systems biology of vascular endothelial growth factorsModified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic miceCaloric restriction stimulates revascularization in response to ischemia via adiponectin-mediated activation of endothelial nitric-oxide synthaseExercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice.Obesity induced-insulin resistance causes endothelial dysfunction without reducing the vascular response to hindlimb ischemia.Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells.Image-guided pro-angiogenic therapy in diabetic stroke mouse models using a multi-modal nanoprobe.Glycemic control influences serum angiogenin concentrations in patients with type 2 diabetesFoxO1 gain of function in the pancreas causes glucose intolerance, polycystic pancreas, and islet hypervascularization.Nitrite anion therapy protects against chronic ischemic tissue injury in db/db diabetic mice in a NO/VEGF-dependent manner.Laser and LED phototherapies on angiogenesis.De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation.Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery diseaseVascular remodeling after ischemic stroke: mechanisms and therapeutic potentialsInduced pluripotent stem cells as a model for diabetes investigation.Mitofusins are required for angiogenic function and modulate different signaling pathways in cultured endothelial cells.Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation.Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers.Myoblast-conditioned media improve regeneration and revascularization of ischemic muscles in diabetic mice.Overexpression of angiopoietin-2 impairs myocardial angiogenesis and exacerbates cardiac fibrosis in the diabetic db/db mouse model.Collaterals: Implications in cerebral ischemic diseases and therapeutic interventionsHydrogen sulfide stimulates ischemic vascular remodeling through nitric oxide synthase and nitrite reduction activity regulating hypoxia-inducible factor-1α and vascular endothelial growth factor-dependent angiogenesis.Downregulation of vascular endothelial growth factor receptor-2 under oxidative stress conditions is mediated by β-transduction repeat-containing protein via glycogen synthase kinase-3β signalingExercise-like effects by Estrogen-related receptor-gamma in muscle do not prevent insulin resistance in db/db mice.Matrix metalloproteinases and cardiovascular diseases.Vascularization pattern after ischemic stroke is different in control versus diabetic rats: relevance to stroke recovery.Adipokines: a link between obesity and cardiovascular disease.Overcoming disease-induced growth factor resistance in therapeutic angiogenesis using recombinant co-receptors delivered by a liposomal system.Tumor necrosis factor inhibition increases the revascularization of ischemic hind-limbs in diabetic mice.Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus.Short-term akt activation in cardiac muscle cells improves contractile function in failing hearts.Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice.Inhibiting the response to VEGF in diabetes.Structure, function, and regulation of mitofusin-2 in health and disease.Human Placenta-Derived Mesenchymal Stromal-Like Cells Enhance Angiogenesis via T Cell-Dependent Reprogramming of Macrophage Differentiation.
P2860
Q24294242-17BCC1DF-023E-4DE5-831F-7937DE2825E9Q28118225-59A8E759-FF88-4E37-A79D-65E521D279E3Q30431481-7516A327-0A65-441D-842F-F351C0FFC64DQ30432040-A26A8FDF-B72B-4CC1-9A05-C1771CB24B91Q30438979-6AE7D6C5-50AB-4750-979C-150FDD1CF2BCQ30503408-EC19AC29-21EC-44B5-9EE1-E985ED186B90Q30850845-A595BAA0-188A-4207-BC7D-BB4EDA593000Q33331474-E882D51C-BEFF-4BCB-9973-570C3C3BE868Q33472763-086DA5CD-E035-4AD7-B945-BAB5EA8C1506Q33553042-7E99049F-19E5-41FD-9607-3D939D22FE90Q33779819-B7475E7B-64A5-487C-ACFA-93E8A10A5265Q34016097-432E712F-7F19-4072-A203-793B08A8852BQ34182405-BC554CD4-F006-4EF9-9EF0-D88CA7D3ECFDQ34263955-475CA700-D502-4FB2-A5A8-235F3D5D8535Q34393851-BFA6C7C2-ABCD-4CD9-ABB1-1ABD3245BF40Q34509518-3FE81DBB-AD99-439F-8758-EB198528EB26Q34536887-895E867F-9919-46B3-8924-CB651D53EB2AQ34641120-0F9DC86B-8B40-482A-A564-2A7E9A85332FQ34972793-379D6133-1F66-46C0-8272-22DD84AC6D0DQ35123614-B3FB69B3-AC85-4A03-93EB-F55CADB4FF1DQ35529133-AC25EF1E-CA06-47C3-9930-23A413F015CFQ35534242-E1334DAA-6FFD-4519-B13B-397FA0CFAC80Q35581211-CB7B338E-E305-425E-9344-2509D9E58F42Q35606014-F725E380-6263-4C5D-B12E-827EFFD9ADA7Q35879163-057BB31D-959A-4C87-A17E-A05EA281E5AFQ36053227-635E2BDA-61EC-48DB-A90E-142875445EA6Q36522675-7423B71C-64CE-42AB-9780-4862EC09674DQ36684301-BEA8C83C-A21D-434E-B715-405AB21FB5D8Q36933850-2111EAAA-5FD5-465F-9BDA-D1A3E195EE34Q37195730-6180F8C5-379B-41EC-B0AF-5862EC1A2ED9Q37307286-5BB9E7A7-129E-446A-AA82-04C56D4E5AC7Q37707281-684D6503-929A-40B6-A61D-29A2568DD9F5Q38311837-BE8E7597-047C-412A-AA45-6C86443F2DACQ40886824-28F62DAC-38EF-48BD-A357-0DA8C9D71BA8Q41763265-E3D31D53-0B12-4929-8C90-E220E8F3D688Q42044656-C7CD627E-B273-406D-8EE0-6E6FBE403BE9Q42738987-1518F395-7E19-4F7F-8C82-B81F894DFC93Q46001182-DB3AFD3C-A250-46A3-A301-E9B03BAB3A43Q47606530-D4C2E262-564B-4B52-B241-8D770B6A87A8Q48199182-4C666A67-F367-4647-AEAE-2665186B6CE1
P2860
Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Impaired revascularization in ...... angiogenic-regulatory network.
@ast
Impaired revascularization in ...... angiogenic-regulatory network.
@en
type
label
Impaired revascularization in ...... angiogenic-regulatory network.
@ast
Impaired revascularization in ...... angiogenic-regulatory network.
@en
prefLabel
Impaired revascularization in ...... angiogenic-regulatory network.
@ast
Impaired revascularization in ...... angiogenic-regulatory network.
@en
P2093
P1476
Impaired revascularization in ...... angiogenic-regulatory network
@en
P2093
Benjamin J Kraus
Kaori Sato
Kenneth Walsh
Stephan Schiekofer
P304
P356
10.1161/01.ATV.0000171994.89106.CA
P407
P577
2005-05-26T00:00:00Z